Vicky Mcgrath

1 result

Spending on high-tech drugs has increased from €400 million in 2012 to €700 million this year, the committee heard. Photograph: Getty Images
High prices causing delays in approving breakthrough drugs, says HSE

The Health Service Executive saved €28 million over five years on a single drug by delaying a decision on its approval, an Oireachtas committee has he(...)